Dr. Ioannis Parastatidis, MD, PhD

Dr. Parastatidis practices at Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System.

Dr. Parastatidis' NPI, 1578727038, was assigned on July 14, 2008. Dr. Parastatidis holds Georgia license 067025.

Dr. Parastatidis' primary practice is Northeast Georgia Medical Center Gainesville, at 743 Spring Street, Gainesville, GA 30501 in Hall County. The practice phone is (770) 535-3553.

Dr. Parastatidis' primary practice is Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System. Dr. Parastatidis is also affiliated with Union General Hospital. The medical group on file is Georgia Heart Institute. Dmand AI also links Dr. Parastatidis to 3 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parastatidis practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Parastatidis' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Parastatidis is licensed in Georgia.

CMS data shows 4,945 Medicare services from Dr. Parastatidis across 36 procedure codes in 2024, for 1,999 Medicare patients. Medicare paid $173,453 for them.

CMS counts 1,999 Medicare patients who saw Dr. Parastatidis in 2024. The largest group is 75 to 84, with 849 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parastatidis' median patient age at 75, with 51% women.

In 2024, Dr. Parastatidis wrote 6,958 Medicare Part D claims for 920 patients. 84% of them were for generic drugs. CMS names the drug for 6,608 of them, across 67 drugs with 11 or more claims each, at $1,168,713 in total drug cost. In 2023, CMS named 6,742 claims across 60 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Parastatidis for performance year 2024, reported as part of a group. Dr. Parastatidis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Parastatidis, published from 2012 to 2024. 2012 was the busiest year, with 2. The most frequent topics are Cells, Cultured, Disease Models, Animal and Myocytes, Smooth Muscle. Dr. Parastatidis has published most often in Arterioscler Thromb Vasc Biol. Dr. Parastatidis' most frequent co-authors are Stamatios Lerakis, MD, Vasilis C. Babaliaros, MD and Vinod H. Thourani, MD.

CMS Open Payments shows 77 general payments to Dr. Parastatidis from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Edwards Lifesciences Corporation paid the most, $2,206.